Pharmafile Logo
Pharmafocus logo
Advanced Search
anderw_mackie_picture

Ergomed strengthens management team and board

July 15, 2015
Research and Development, Sales and Marketing Andrew Mackie, ergomed

UK-based drug development company Ergomed has appointed Andrew Mackie as chief business officer, and to its board as executive director.Mackie …

Appointment
The Francis Crick Institute

GSK and the Francis Crick Institute collaborate on drug R&D

July 15, 2015
Research and Development Francis Crick Institute, GSK, R&D, The Crick, medical research

The UK’s largest pharma company and the UK’s newest biomedical research facility are partnering up to begin an innovation collaboration.The …

News
Public Health England

Public Health England and Imperial Innovations boost UK life sciences sector

July 14, 2015
Manufacturing and Production, Research and Development Imperial Innovations, Public Health England, R&D, investment, life sciences, spin-puts

The Government has signed-off on the transfer of Public Health England’s drug development and production arm into a state-owned biopharma …

News
Life sciences minister George Freeman

Government launches Accelerated Access Review call to action

July 14, 2015
Research and Development Accelerated Access Review, Sir Hugh Taylor, UK, george freeman, john bell, life sciences minister

The Government is urging pharma companies to participate in the Accelerated Access Review, and will launch a website for firms …

News
Rexulti (brexpiprazole)

FDA approves Lundbeck and Otsuka’s Rexulti for depression

July 14, 2015
Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia

Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …

News

Chancellor announces drug R&D funding boost in Catapult expansion

July 14, 2015
Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy

Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …

News
Actavis facility in Iceland

Allergan closing manufacturing facility in Iceland

July 14, 2015
Manufacturing and Production Actavis, Allergan, Iceland, manufacturing, production, redundancies

Actavis is shutting a plant in Iceland, where its recently-acquired company Actavis has roots, and cutting 300 jobs in the …

News

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015
Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …

News
Astellas' Ken Jones

Diary of a decade – Ten years in Europe, the Middle East and Africa

July 13, 2015
Medical Communications, Sales and Marketing Astellas, Ken Jones

It’s hard to imagine how much a company can change in a decade.When Astellas Pharma Europe was launched 10 years …

Feature
roche__tree

Roche posts positive mid-stage trial results for atezolizumab

July 13, 2015
Research and Development Genentech, PD-L1, Phase II, Roche, anti-PD-L1, atezolizumab, clinical trial, immuno-oncology, personalised medicine

A cancer drug in development by Roche has performed well in a mid-phase clinical trial – prompting the Swiss firm …

News

Novo Nordisk pushes forward with new diabetes drug trial

July 13, 2015
Research and Development GLP-1 agonist, Novo Nordisk, diabetes, phase III, semaglutide, type 2 diabetes

Novo Nordisk is taking the first steps towards adding another type 2 diabetes drug to its portfolio, after announcing positive …

News
Daiichi Sankyo

NICE recommends Daiichi’s Lixiana for blood clots

July 13, 2015
Sales and Marketing DVT, Daiichi, Daiichi Sankyo, Lixiana, NICE, NOACs, VTE, anticoagulant, blood clots, edoxaban, novel anticoagulant. PE

Daiichi Sankyo has won a speedy approval from NICE, after the NHS guidance body approved its newly-launched blood clotting drug …

News
6127242068_23c80ef94f_z

Pharma dominates global M&A activity

July 10, 2015
Sales and Marketing M&A, MA, acquisitions, mergers, takeovers

Mergers and acquisitions in the pharma, medical and biotech sectors have hit the highest levels in nearly 15 years, a …

News
Entyvio

NICE u-turns on Entyvio for Crohn’s disease

July 10, 2015
Medical Communications, Sales and Marketing Crohn's, Crohn’s disease, Entyvio, Millenium, NICE, Takeda, funding

NICE has performed a u-turn and recommended drug treatment Entyvio for Crohn’s disease for routine NHS funding.In final draft guidance …

News
Daiichi image

Daiichi Sankyo launches clotting drug Lixiana in UK

July 10, 2015
Medical Communications, Sales and Marketing Daiichi Sankyo, Lixiana, NOAC, VTE, anticoagulant, atrial fibrillation, blood clots, edoxaban, novel anticoagulant, strokes, warfarin

Daiichi Sankyo’s Lixiana has become the latest pharma offering in the class of newer oral anticoagulants in the UK.Lixiana (edoxaban) …

News
hugh-sampson-10

Allergy expert Dr Hugh Sampson joing DBV Technologies

July 9, 2015
Research and Development DBV Technologies, Viaskin

DBV Technologies has appointed Dr Hugh Sampson as its chief scientific officer. The French biotech company is developing the Viaskin peanut allergy treatment patch. Dr …

Appointment
Logos

Praluent scores positive trial results in Japan

July 9, 2015
Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent

Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …

News
package_of_lutera_birth_control_pills

Actavis contraceptives recalled after packaging errors

July 9, 2015
Manufacturing and Production Actavis, FDA, manufacturing, packaging, product recall, production, recalls

Actavis is voluntarily recalling more than half a million boxes of contraceptive pills in the United States due to problems …

News
Deopmed logo

Horizon attempts a hostile $3bn Depomed takeover

July 9, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover

Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …

News
NHS Westminster

Conservative announce NHS to receive a further £8 billion by 2020

July 9, 2015
Budget, Chancellor, Chancellor of the exchequer, Conservatives, George Osborne, NHS, NHS funding, Tories, funding, government

The Conservative Government has confirmed the NHS will receive £10 billion in funding by 2020 in the Chancellor’s budget announcement.The …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026